1. Home
  2. LABT vs YCBD Comparison

LABT vs YCBD Comparison

Compare LABT & YCBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lakewood-Amedex Biotherapeutics Inc. Common Stock

LABT

Lakewood-Amedex Biotherapeutics Inc. Common Stock

N/A

Current Price

$2.29

Market Cap

5.3M

Sector

Health Care

ML Signal

N/A

Logo cbdMD Inc.

YCBD

cbdMD Inc.

HOLD

Current Price

$0.51

Market Cap

6.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LABT
YCBD
Founded
N/A
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.3M
6.0M
IPO Year
2026
2018

Fundamental Metrics

Financial Performance
Metric
LABT
YCBD
Price
$2.29
$0.51
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$2.00
AVG Volume (30 Days)
191.1K
168.6K
Earning Date
N/A
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
39.11
EPS
N/A
N/A
Revenue
N/A
$19,190,468.00
Revenue This Year
N/A
$12.70
Revenue Next Year
N/A
$7.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.66
$0.47
52 Week High
$6.85
$2.56

Technical Indicators

Market Signals
Indicator
LABT
YCBD
Relative Strength Index (RSI) 43.95 40.23
Support Level $2.07 $0.47
Resistance Level $2.48 $0.84
Average True Range (ATR) 0.21 0.04
MACD 0.03 -0.00
Stochastic Oscillator 39.64 21.19

Price Performance

Historical Comparison
LABT
YCBD

About LABT Lakewood-Amedex Biotherapeutics Inc. Common Stock

Lakewood-Amedex Biotherapeutics Inc is a clinical-stage biotechnology company developing a novel class of fast-acting, broad-spectrum antimicrobials - the Bisphosphocin class - to treat infectious diseases and reduce the threat posed by antibiotic-resistant bacterial strains, including MRSA, VRE, and others. The company's main product is Nu-3, a topically delivered antimicrobial gel in Phase 2 clinical trials for the treatment of mildly infected diabetic foot ulcers (iDFU). It is also advancing a portfolio of early-stage pipeline compounds developed from its Bisphosphocin platform targeting potential disease indications, including complicated urinary tract infection (cUTI) and pulmonary infections.

About YCBD cbdMD Inc.

cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.

Share on Social Networks: